Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of West Pharmaceutical Services, Inc. (“West Pharmaceutical” or the “Company”) (NYSE: WST).
On May 5, 2025, a class action complaint for violations of federal securities laws was filed against West Pharmaceutical in United States District Court, Eastern District of Pennsylvania, on behalf of investors who purchased or otherwise acquired West Pharmaceutical common stock between February 16, 2023 and February 12, 2025, both dates inclusive (the “Class Period”).
Throughout the Class Period, according to the complaint, the West Pharmaceutical Defendants allegedly misled investors by failing to disclose that 1) despite claiming strong visibility into customer demand and attributing headwinds to temporary COVID-related product destocking, West Pharmaceutical was, in fact, experiencing significant and ongoing destocking across its high-margin High-Value Products portfolio; 2) the Company’s SmartDose device was highly dilutive to the Company’s profit margins due to operational inefficiencies; and 3) these margin pressures created the risk of costly restructuring activities, including the Company’s exit from continuous glucose monitoring contracts with long-standing customers.
To review a copy of the complaint, please click West Pharmaceutical Class Action Complaint.
West Pharmaceutical Investors May Have Legal Claims
Investors who acquired West Pharmaceutical stock during the Class Period are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or send us a message to contact an attorney for a free, no-obligation evaluation of potential legal claims.
West Pharmaceutical investors can also contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected].
About Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.
Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.
Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.
SEND US A MESSAGE
Contact Us
ADDRESS
Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103